Targeted Inhibition of the Epidermal Growth Factor Receptor and Mammalian Target of Rapamycin Signaling Pathways in Olmsted Syndrome.

Zhang, April

Targeted Inhibition of the Epidermal Growth Factor Receptor and Mammalian Target of Rapamycin Signaling Pathways in Olmsted Syndrome. [electronic resource] - JAMA dermatology 02 2020 - 196-200 p. digital

Publication Type: Case Reports; Journal Article

2168-6084

10.1001/jamadermatol.2019.4141 doi


Adolescent
Brazil
Child
Child, Preschool
ErbB Receptors--antagonists & inhibitors
Erlotinib Hydrochloride--administration & dosage
Female
Humans
Immunosuppressive Agents--administration & dosage
Infant
Keratoderma, Palmoplantar--drug therapy
Male
Protein Kinase Inhibitors--administration & dosage
Signal Transduction--drug effects
Sirolimus--administration & dosage
Syndrome
TOR Serine-Threonine Kinases--antagonists & inhibitors
Treatment Outcome